Bio-Connect
Cat # C2011
Cat # C2011
Cat # C2011

Medium Polysulfone Fiber Cartridge (20kD MWCO)

Research Use Only
C2011
FiberCell Systems
Product group Labware / Accesories
€ 682,00
1 ea
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    FiberCell Systems
  • Product Name
    Medium Polysulfone Fiber Cartridge (20kD MWCO)
  • Delivery Days Customer
    6
  • Certification
    Research Use Only
  • Scientific Description
    High MWCO (20 kD @ 50%) hydrophilic polysulfone fiber for monoclonal antibodies and larger recombinant proteins (100 kD or larger). Can support up to 109 cells and produce 1-5 mg of a recombinant protein every day or 5-100 mg of a monoclonal antibody every other day. This is the cartridge of choice for PK/PD studies.
  • UNSPSC
    41100000

References

  • Kroemer N, Amann LF, Farooq A, et al. Pharmacokinetic/pharmacodynamic analysis of ceftazidime/avibactam and fosfomycin combinations in an in vitro hollow fiber infection model against multidrug-resistant Escherichia coli. Microbiol Spectr. 2024;12(1):e0331823.
    Read more
  • Jimenez L, Barman B, Jung YJ, et al. Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations. J Extracell Vesicles. 2023;12(11):e12366.
    Read more
  • Wang Y, Worrell GA, Wang HL. It is the frequency that matters: effects of electromagnetic fields on the release and content of extracellular vesicles. bioRxiv. Published online August 11, 2023:2023.08.08.552505.
    Read more
  • LaPlante EL, Stürchler A, Fullem R, et al. Exrna-eclip intersection analysis reveals a map of extracellular rna binding proteins and associated rnas across major human biofluids and carriers. Cell Genom. 2023;3(5):100303.
    Read more
  • Van den Broek B, Wuyts C, Sisto A, et al. Oligodendroglia-derived extracellular vesicles activate autophagy via LC3B/BAG3 to protect against oxidative stress with an enhanced effect for HSPB8 enriched vesicles. Cell Commun Signal. 2022;20(1):58.
    Read more
  • Horspool AM, Sen-Kilic E, Malkowski AC, et al. Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244. Front Cell Infect Microbiol. 2023;13:1117844.
    Read more
  • Priedols M, Paidere G, Santos CB, et al. Bifurcated asymmetric field flow fractionation of nanoparticles in pdms-free microfluidic devices for applications in label-free extracellular vesicle separation. Polymers (Basel). 2023;15(4):789.
    Read more
  • Zhang C, Huo X, Zhu Y, et al. Electrodeposited magnetic nanoporous membrane for high-yield and high-throughput immunocapture of extracellular vesicles and lipoproteins. Commun Biol. 2022;5(1):1358.
    Read more
  • Krishna A, Zere T, Mistry S, et al. Evaluation of a sequential antibiotic treatment regimen of ampicillin, ciprofloxacin and fosfomycin against escherichia coli cft073 in the hollow fiber infection model compared with simultaneous combination treatment. Antibiotics (Basel). 2022;11(12):1705.
    Read more
  • Ferran AA, Lacroix MZ, Gourbeyre O, et al. The selection of antibiotic- and bacteriophage-resistant pseudomonas aeruginosa is prevented by their combination. Microbiol Spectr. 2022;10(5):e0287422.
    Read more